Showing results (101-110 of 266) with videos related to
Sort By:
Pageof 27
Public Health Reports (Washington, D.C. : 1974)|April 23, 2010
Enrollment in outpatient care among newly released prison inmates with HIV infectionJacques G Baillargeon, Thomas P Giordano, Amy Jo Harzke, et al.Drug and Alcohol Dependence|March 28, 2007
Lower syringe sharing and re-use after syringe legalization in Rhode IslandJosiah D Rich, Joseph W Hogan, Francis Wolf, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 16, 2013
Correctional facilities as partners in reducing HIV disparitiesJosiah D Rich, Ralph DiClemente, Judith Levy, et al.American Journal of Public Health|November 14, 2014
Survey of US Correctional Institutions for Routine HCV TestingCurt G Beckwith, Ann E Kurth, Lauri Bazerman, et al.American Journal of Public Health|July 1, 2004
Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisonsGrace E Macalino, David Vlahov, Stephanie Sanford-Colby, et al.The AIDS Reader|January 7, 2009
Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode IslandJennifer A Mitty, Lauri B Bazerman, Kyra Selwyn, et al.Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 1, 2013
Increasing hepatitis C prevalence and associated risk behaviors among incarcerated young adultsBlair C McNamara, Phyllis T Losikoff, Linda Huguenin, et al.American Journal of Public Health|January 18, 2014
Medicaid policies and practices in US state prison systemsDavid L Rosen, Dora M Dumont, Andrew M Cislo, et al.Open Forum Infectious Diseases|May 19, 2016
Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange ProgramsJoshua A Barocas, Benjamin P Linas, Arthur Y Kim, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2011
Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapyRyan P Westergaard, Gregory D Kirk, Douglas R Richesson, et al.Pageof 27